Cellectis, Pioneer Meganuclease deal

Cellectis (Paris, France) granted non-exclusive rights to its Meganuclease Recombinant System (MRS) to Pioneer Hi-Bred (Des Moines, Iowa), a subsidiary of Dupont (DD). Pioneer will use the homologous ...